Naftopidil

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Naftopidil
Naftopidil.png
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 57149-07-2 YesY
PubChem (CID) 4418
ChemSpider 4265 N
UNII R9PHW59SFN YesY
ECHA InfoCard 100.220.557
Chemical and physical data
Formula C24H28N2O3
Molar mass 392.49 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Naftopidil (INN, marketed under the brand name Flivas) is a drug used in benign prostatic hypertrophy which acts as a selective α1-adrenergic receptor antagonist or alpha blocker.[1]

See also[edit]

References[edit]

  1. ^ Sakai H, Igawa T, Onita T, Furukawa M, Hakariya T, Hayashi M, Matsuya F, Shida Y, Nishimura N, Yogi Y, Tsurusaki T, Takehara K, Nomata K, Shiraishi K, Shono T, Aoki D, Kanetake H (2011). "Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication". Hinyokika Kiyo. 57 (1): 7–13. PMID 21304253.